home / news / Study team co-investigators updated

Our Monthly Scientific Selection: February Publications on EuroQol Instruments #2

March 13, 2025
[1-28 February 2025] Zhou W, Ding B, Busschbach J, Herdman...

Open Call for Abstracts: 42nd EuroQol Plenary 2025

March 3, 2025
The Call for Abstracts for the 42nd EuroQol Plenary 2025...

Our Monthly Scientific Selection: January Publications on EuroQol Instruments #1

February 11, 2025
[1-31 January 2025] Dincer M, Akyol M, Karatas YE, Kocakaya...

Our Monthly Scientific Selection: December Publications on EuroQol Instruments #12

January 21, 2025
[1-31 December 2024] Sanghera S, Coast J, Walther A, Peters...

Meeting of EQ-5D researchers in the UK and Ireland

January 6, 2025
REGISTRATION NOW OPEN! Following the success of the first meeting,...
August 16, 2022

Study team co-investigators updated

The research team for the UK EQ-5D-5L valuation study has been updated. The lead investigator is Donna Rowen (School of Health and Related Research, University of Sheffield) and co-investigators are:

  • Nathan Bray (Centre for Health Economics and Medicines Evaluation, Bangor University)
  • Jill Carlton (School of Health and Related Research, University of Sheffield)
  • Louise Longworth (PHMR, London)
  • David Meads (Academic Unit of Health Economics, Leeds Institute for Health Sciences, University of Leeds)
  • Clara Mukuria (School of Health and Related Research, University of Sheffield)
  • Ciaran O’Neill (Centre for Public Health, Queens University Belfast)
  • Yaling Yang (Nuffield Department of Primary Care Health Sciences, University of Oxford)

This team has been carefully selected by the project’s Steering Group and will bring significant experience and expertise to the valuation study.